Prevalence of Cardiovascular Risk Factors in Upper Vestibular Neuritis

Prevalence of Cardiovascular Risk Factors in People With Upper Vestibular Neuritis

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04926363

Acronym

NEVRITE

Enrollment

150

Registered

2021-06-15

Start date

2020-02-01

Completion date

2022-02-04

Last updated

2021-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular Neuritis

Keywords

Vestibular neuritis, Anterior vestibular artery

Brief summary

Vestibular neuritis is the second cause of vertigo, it constitutes 5 to 6% of the aetiologies of vertigo in an otoneurological consultation. Infection or reactivation of a neurotropic virus of the herpes group (HSV-1) in the vestibular lymph node is thought to be the cause of the unilateral vestibular deficit. Upper vestibular neuritis is more common than lower, or total involvement. Goebel (2) explains this by an anatomical predisposition of the vestibular nerve canal to inflammation, unlike the singular nerve canal which is shorter and wider giving way to a certain degree of edema without consequence on its contents. However, the innervation territory of the superior vestibular nerve is superimposable on the territory supplied by the anterior vestibular artery. The anterior, lateral semicircular canals and the utricle are affected. Current complementary vestibular and imaging examinations cannot differentiate between inflammatory or vascular involvement in upper vestibular neuritis. The increased presence of cardiovascular risk factors in patients with upper vestibular neuritis would be an argument in favor of ischemic involvement of the anterior vestibular artery.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

nclusion criteria: * Major subject (≥18 years old), * Subject having presented an episode of upper vestibular neuritis recorded on the Video Head Impulse Test Ulmer device at the HUS between 01/01/2016 and 01/31/2020, * Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

* Patient who expressed his opposition to participating in the study, * Total vestibular neuritis, * impossibility of providing the subject with enlightened information (difficulties in understanding the subject, etc.) * Subject under safeguard of justice, * Subject under guardianship or guardianship, * Lack of video head impulse test data.

Design outcomes

Primary

Measure	Time frame
Retrospective study of cardiovascular risk factors in people with upper vestibular neuritis	Files analysed retrospectively from January 01, 2016 to January 31, 2020 will be examined]

Countries

France

Contacts

Primary ContactAnne CHARPIOT, MD, PhD

anne.charpiot@chru-strasbourg.fr33 3 88 12 76 41

Backup ContactSaïd CHAYER, PhD, HDR

said.chayer@chru-strasbourg.fr33 3 88 11 66 90

Outcome results